WeVote
Log In

Bill

WeVote Research Nonpartisan
Bill Summary · HB 592

Legislative bill overview

HB 592 establishes requirements for medical device manufacturers to eliminate or reduce toxic substances in their products sold in North Carolina. The bill creates standards for what constitutes "toxic-free" medical devices and likely includes reporting and compliance mechanisms for manufacturers. It represents North Carolina's attempt to align medical device safety standards with emerging health concerns about chemical exposure through medical equipment.

Why is this important

Medical devices have direct contact with patients' bodies, making chemical composition a legitimate public health concern. Some medical devices contain flame retardants, phthalates, and other chemicals linked to health issues; this bill could reduce patient exposure to these substances. However, implementation costs could affect device availability and pricing in the state.

Potential points of contention

  • Manufacturing compliance costs: Reformulating devices to meet "toxic-free" standards requires significant R&D investment, which manufacturers may pass to consumers or restrict product lines in North Carolina
  • Definition ambiguity: The bill's specific definition of "toxic" substances and safe thresholds is crucial; overly broad definitions could eliminate necessary medical devices while narrow ones may be ineffective
  • Federal preemption concerns: Medical devices are heavily regulated by the FDA; state-level requirements could conflict with federal standards or create a patchwork of state regulations that complicates national distribution

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.